Daniele Mauro Selected Research

Multifocal fibrosclerosis

1/2022

Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Mauro Research Topics

Disease

6	Rheumatoid Arthritis 12/2018 - 09/2012
4	Arthritis (Polyarthritis) 04/2022 - 12/2018
4	Inflammation (Inflammations) 01/2021 - 01/2018
2	Ankylosing Spondylitis 01/2021 - 11/2019
2	Dysbiosis 01/2021 - 12/2019
2	Axial Spondyloarthritis 01/2020 - 01/2019
2	Insulin Resistance 05/2015 - 09/2012
2	Anemia 01/2009 - 01/2009
1	Fatigue 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022
1	Chronic Disease (Chronic Diseases) 04/2022
1	HIV Infections (HIV Infection) 01/2022
1	Psoriatic Arthritis 01/2022
1	COVID-19 01/2022
1	Multifocal fibrosclerosis 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Nephritis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Ileitis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Lupus Nephritis 01/2021
1	Proteinuria 01/2021
1	Multiple Sclerosis 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Non-alcoholic Fatty Liver Disease 10/2017
1	Fatty Liver 10/2017

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2017
2	C-Reactive ProteinIBA 01/2021 - 10/2017
2	Complement C3 (C3 Complement)IBA 01/2018 - 10/2017
2	Abatacept (Orencia)FDA Link 05/2015 - 09/2012
1	Immunomodulating AgentsIBA 04/2022
1	SteroidsIBA 04/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	BNT162 VaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	guselkumabIBA 01/2022
1	iberdomideIBA 01/2021
1	curdlanIBA 01/2021
1	c-Mer Tyrosine KinaseIBA 01/2021
1	CreatinineIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	InflammasomesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	LigandsIBA 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	secukinumabIBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	AntibodiesIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	AutoantibodiesIBA 12/2018
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	AntigensIBA 12/2018
1	RadiopharmaceuticalsIBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Complement System Proteins (Complement)IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2012
1	ThymolIBA 01/2009
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2019
1	Biological Therapy 12/2019
1	Aftercare (After-Treatment) 09/2012